These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 7684192)
21. A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma. Taylor SR; Locker J Cancer; 1990 Mar; 65(6):1360-6. PubMed ID: 2306684 [TBL] [Abstract][Full Text] [Related]
22. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method. Bhargava R; Oppenheimer O; Gerald W; Jhanwar SC; Chen B Diagn Mol Pathol; 2005 Jun; 14(2):72-6. PubMed ID: 15905689 [TBL] [Abstract][Full Text] [Related]
23. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658 [TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma). Lorenzana AN; Zielenska M; Thorner P; Gerrie B; Weitzman S; Squire J Pediatr Pathol Lab Med; 1997; 17(6):875-83. PubMed ID: 9353827 [TBL] [Abstract][Full Text] [Related]
26. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528 [TBL] [Abstract][Full Text] [Related]
27. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382 [TBL] [Abstract][Full Text] [Related]
28. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR. Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551 [TBL] [Abstract][Full Text] [Related]
29. Morphologic and molecular cytogenetics in neuroblastoma. Avet-Loiseau H; Venuat AM; Benard J; Leibovitch MP; Hartmann O; Bernheim A Cancer; 1995 Apr; 75(7):1694-9. PubMed ID: 8826929 [TBL] [Abstract][Full Text] [Related]
30. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas. Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310 [TBL] [Abstract][Full Text] [Related]
31. Detection of amplified N-myc gene in neuroblastoma by in situ hybridization using the single-step silver enhancement method. Noguchi M; Hirohashi S; Tsuda H; Nakajima T; Hara F; Shimosato Y Mod Pathol; 1988 Nov; 1(6):428-32. PubMed ID: 3222254 [TBL] [Abstract][Full Text] [Related]
32. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma. Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241 [TBL] [Abstract][Full Text] [Related]
33. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines. Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240 [TBL] [Abstract][Full Text] [Related]
34. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876 [TBL] [Abstract][Full Text] [Related]
35. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance]. Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585 [TBL] [Abstract][Full Text] [Related]
36. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999 [TBL] [Abstract][Full Text] [Related]
37. Automatic quantification of gene amplification in clinical samples by IQ-FISH. Narath R; Lörch T; Rudas M; Ambros PF Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059 [TBL] [Abstract][Full Text] [Related]
38. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification. Souzaki R; Tajiri T; Teshiba R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T J Pediatr Surg; 2011 Dec; 46(12):2228-32. PubMed ID: 22152855 [TBL] [Abstract][Full Text] [Related]
39. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236 [TBL] [Abstract][Full Text] [Related]
40. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas. Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]